Amino Acid Transporters as Potential Therapeutic Targets in Thyroid Cancer

Endocrinol Metab (Seoul). 2020 Jun;35(2):227-236. doi: 10.3803/EnM.2020.35.2.227. Epub 2020 Jun 24.

Abstract

Thyroid cancer cells have a high amino acid demand for proliferation, invasion, and metastasis. Amino acids are taken up by thyroid cancer cells, both thyroid follicular cell and thyroid parafollicular cells (commonly called "C-cells"), via amino acid transporters. Amino acid transporters up-regulate in many cancers, and their expression level associate with clinical aggressiveness and prognosis. This is the review to discuss the therapeutic potential of amino acid transporters and as molecular targets in thyroid cancer.

Keywords: 2-amino-3-(4-((5-amino-2-phenylbenzo(d)oxazol-7-yl)methoxy)-3,5-dichlorophenyl)propanoic acid; Amino acid transport systems; Boron neutron capture therapy; Large neutral amino acid-transporter 1; Proto-oncogene proteins c-myc; Thyroid neoplasms.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Transport Systems / antagonists & inhibitors*
  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Molecular Targeted Therapy*
  • Proto-Oncogene Mas
  • Thyroid Neoplasms / drug therapy*
  • Thyroid Neoplasms / metabolism
  • Thyroid Neoplasms / pathology

Substances

  • Amino Acid Transport Systems
  • Antineoplastic Agents
  • MAS1 protein, human
  • Proto-Oncogene Mas